Načítá se...
Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog
BACKGROUND: Endostatin (ES) is a well-established potent endogenous antiangiogenic factor. An ES variant, called zinc-binding protein-ES (ZBP-ES), is clinically available; however, its use is limited by rapid renal clearance and short residence time. PEGylation has been exploited to overcome these s...
Uloženo v:
| Vydáno v: | Chin J Cancer |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4721152/ https://ncbi.nlm.nih.gov/pubmed/26792627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-016-0080-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|